Crossref
Diagnostic Value of PSA Screening Combined with Multiparametric MRI in Differentiating Prostate Cancer in the PSA Gray Zone (4.0–10.0 ng/mL)
Research journal · 2025 · 1 (1)
DOI: 10.65281/736336 ↗At a glance
Journal article in Research journal, 2025. Written by Senlin Hou and 8 co-authors.
Abstract (original language)
Niciun rezumat disponibil.
Cite
APA
Hou, S., Xiong, M., Xu, B., Zhao, D., Du, Z., Fu, D., Lu, W., Hou, J., & Chen, W. (2025). Diagnostic Value of PSA Screening Combined with Multiparametric MRI in Differentiating Prostate Cancer in the PSA Gray Zone (4.0–10.0 ng/mL). Research journal, 1(1). https://doi.org/10.65281/736336
Vancouver
Hou S, Xiong M, Xu B, Zhao D, Du Z, Fu D, et al. Diagnostic Value of PSA Screening Combined with Multiparametric MRI in Differentiating Prostate Cancer in the PSA Gray Zone (4.0–10.0 ng/mL). Research journal. 2025;1(1). doi:10.65281/736336
BibTeX
@article{Hou2025,
author = {Hou, Senlin and Xiong, Ming and Xu, Binxian and Zhao, Duze and Du, Zhinan and Fu, Dongjun and Lu, Wei and Hou, Junqing and Chen, Weiguo},
title = {Diagnostic Value of PSA Screening Combined with Multiparametric MRI in Differentiating Prostate Cancer in the PSA Gray Zone (4.0–10.0 ng/mL)},
journal = {Research journal},
year = {2025},
volume = {1},
number = {1},
doi = {10.65281/736336}
}
EUVIMED